Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.240
-0.060 (-4.62%)
At close: Jul 17, 2026
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of €334.92 million as of July 17, 2026. Its market cap has decreased by -39.79% in one year.
Market Cap
334.92M
Enterprise Value
456.99M
Revenue
80.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.24
ChartMarket Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from 833.42M to 334.92M, a decrease of -59.81%. That is a compound annual growth rate of -10.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 334.92M | -25.75% |
| Dec 31, 2025 | 451.08M | -25.33% |
| Dec 31, 2024 | 604.06M | -40.39% |
| Dec 29, 2023 | 1.01B | 229.38% |
| Dec 30, 2022 | 307.67M | -7.54% |
| Dec 31, 2021 | 332.77M | -12.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 78.00M |
| 2invest AG | 45.07M |
| Biomark Diagnostics | 33.44M |
| Vidac Pharma Holding | 24.01M |
| co.don AG | 427.57K |
| Paion AG | 392.35K |
| bioXXmed AG | 225.65K |